Get started
BETA DRUGS LTDBETA DRUGS LTDBETA DRUGS LTD

BETA DRUGS LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BETA chart


Full chart

BETA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪18.41 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
44.90
Basic EPS (TTM)
40.60 INR
Net income (FY)
‪364.37 M‬ INR
Revenue (FY)
‪2.95 B‬ INR
Shares float
‪1.86 M‬
Beta (1Y)
0.96

Employees


Employees (FY)
371
Change (1Y)
+56 +17.78%
Revenue / Employee (1Y)
‪7.96 M‬ INR
Net income / Employee (1Y)
‪982.13 K‬ INR

About BETA DRUGS LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
betadrugslimited.com
Headquarters
Panchkula
Founded
2005
ISIN
INE351Y01019
FIGI
BBG00HVHP681
Beta Drugs Ltd. engages in the manufacturing and trading of pharmaceuticals. The firm focuses on manufacturing oncology and dermatology medicines. Its products include adside etoposide, adrea hydroxy urea, adcarb carboplatin, doxorubicin, and adben bendamustine. The company was founded by Vijay Kumar Batra, Inpeet Singh, and Gaganpeet Kaur on September 21, 2005 and is headquartered in Panchkula, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BETA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BETA.

Frequently Asked Questions


The current price of BETA is 1,854.00 INR — it has increased by 1.67% in the past 24 hours. Watch BETA DRUGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange BETA DRUGS LTD stocks are traded under the ticker BETA.
BETA stock has risen by 9.06% compared to the previous week, the month change is a −0.27% fall, over the last year BETA DRUGS LTD has showed a 47.14% increase.
BETA reached its all-time high on Nov 11, 2024 with the price of 2,215.25 INR, and its all-time low was 35.25 INR and was reached on Mar 25, 2020. View more price dynamics on BETA chart.
See other stocks reaching their highest and lowest prices.
BETA stock is 3.53% volatile and has beta coefficient of 0.96. Track BETA DRUGS LTD stock price on the chart and check out the list of the most volatile stocks — is BETA DRUGS LTD there?
Today BETA DRUGS LTD has the market capitalization of ‪18.41 B‬, it has increased by 4.87% over the last week.
Yes, you can track BETA DRUGS LTD financials in yearly and quarterly reports right on TradingView.
BETA DRUGS LTD is going to release the next earnings report on May 15, 2025. Keep track of upcoming events with our Earnings Calendar.
BETA net income for the last half-year is ‪244.36 M‬ INR, while the previous report showed ‪165.64 M‬ INR of net income which accounts for 47.53% change. Track more BETA DRUGS LTD financial stats to get the full picture.
No, BETA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 15, 2025, the company has 371 employees. See our rating of the largest employees — is BETA DRUGS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BETA DRUGS LTD EBITDA is ‪659.48 M‬ INR, and current EBITDA margin is 20.31%. See more stats in BETA DRUGS LTD financial statements.
Like other stocks, BETA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BETA DRUGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BETA DRUGS LTD technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BETA DRUGS LTD stock shows the buy signal. See more of BETA DRUGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.